高绩效院前重症监护系统的插管首次成功率与30天死亡率无关:4496次插管尝试的登记研究
该回顾性观察研究基于芬兰直升机紧急医疗服务国家数据库,分析4496次药物辅助插管尝试,其中4082次(91%)首次尝试即成功。首次成功组与非首次成功组的30天死亡率分别为34%和38%(P=0.21),调整后OR为0.88(95%CI 0.66-1.16)。非首次成功组插管后低氧血症(12% vs. 5%,P<0.001)和交接时低氧血症(5% vs. 3%,P=0.01)更常见,其他并发症无显著差异。作者认为,在当前参数局限下,首次成功率更应视为过程质量指标而非不良结局风险因素。
要点
- 4496次院前药物辅助插管中,首次尝试成功4082次(91%)。
- 首次成功组与非首次成功组30天死亡率分别为34%与38%(P=0.21),调整后OR 0.88(95%CI 0.66-1.16)。
- 非首次成功组插管后低氧血症更常见(12% vs. 5%,P<0.001),交接时低氧血症也更常见(5% vs. 3%,P=0.01)。
- 其他并发症在两组间无显著差异。
- 作者认为,首次成功率更应被视为过程质量指标,而非不良结局的风险因素。
适用人群与场景
- 芬兰直升机紧急医疗服务中接受药物辅助插管的院前危重患者。
研究设计与关键结果
- 回顾性观察研究,数据来自芬兰直升机紧急医疗服务国家数据库,纳入4496次药物辅助插管尝试。
- 首次尝试成功4082次(91%);首次成功组与非首次成功组30天死亡率分别为34%与38%(P=0.21)。
- 首次成功对30天死亡率的调整OR为0.88(95%CI 0.66-1.16)。
- 非首次成功组插管后低氧血症发生率12% vs. 首次成功组5%(P<0.001);交接时低氧血症发生率5% vs. 3%(P=0.01)。
- 其他并发症在两组间无显著差异。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在当前参数局限下,首次成功率更应被视为过程质量指标,而非不良结局的风险因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Lower intubation first-pass success (FPS) rate is associated with physiological deterioration, and FPS is widely used as a quality indicator of the airway management of a critically ill patient. However, data on FPS's association with survival is limited. We aimed to investigate if the FPS rate is associated with 30-day mortality or physiological complications in a pre-hospital setting. Furthermore, we wanted to describe the FPS rate in Finnish helicopter emergency medical services.
METHODS: This was a retrospective observational study. Data on drug-facilitated intubation attempts by helicopter emergency medical services were gathered from a national database and analysed. Multivariate logistic regression, including known prognostic factors, was performed to assess the association between FPS and 30-day mortality, collected from population registry data.
RESULTS: Of 4496 intubation attempts, 4082 (91%) succeeded on the first attempt. The mortality rates in FPS and non-FPS patients were 34% and 38% (P = 0.21), respectively. The adjusted odds ratio of FPS for 30-day mortality was 0.88 (95% CI 0.66-1.16). Hypoxia after intubation and at the time of handover was more frequent in the non-FPS group (12% vs. 5%, P < 0.001, and 5% vs. 3%, P = 0.01, respectively), but no significant differences were observed regarding other complications.
CONCLUSION: FPS is not associated with 30-day mortality in pre-hospital critical care delivered by advanced providers. It should therefore be seen more as a process quality indicator instead of a risk factor of poor outcome, at least considering the current limitations of the parameter.
参考来源
- Ljungqvist H, Pirneskoski J, Saviluoto A, et al. Intubation first-pass success in a high performing pre-hospital critical care system is not associated with 30-day mortality: a registry study of 4496 intubation attempts. Scand J Trauma Resusc Emerg Med. 2022. PMID: 36411447. doi:10.1186/s13049-022-01049-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。